
According to data from Benzinga Pro, during Q1, DarioHealth's (NASDAQ:DRIO) reported sales totaled $8.06 million. Despite a 26.27% increase in earnings, the company posted a loss of $15.92 million. In Q4, DarioHealth brought in $6.03 million in sales but lost $21.59 million in earnings.